Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

514 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sexual risk and HIV testing disconnect in men who have sex with men (MSM) recruited to an online HIV self-testing trial.
Rodger AJ, Dunn D, McCabe L, Weatherburn P, Lampe FC, Witzel TC, Burns F, Ward D, Pebody R, Trevelion R, Brady M, Kirwan PD, Khawam J, Delpech VC, Gabriel M, Collaco-Moraes Y, Phillips AN, McCormack S. Rodger AJ, et al. Among authors: mccormack s. HIV Med. 2020 Oct;21(9):588-598. doi: 10.1111/hiv.12919. Epub 2020 Aug 9. HIV Med. 2020. PMID: 32776431 Free article. Clinical Trial.
The use of HIV resistance assays--random or randomised?
Loveday C, Dunn D, McCormack S, Babiker A. Loveday C, et al. Among authors: mccormack s. Sex Transm Infect. 1999 Jun;75(3):140-1. Sex Transm Infect. 1999. PMID: 10448385 No abstract available.
A randomized controlled trial of the value of phenotypic testing in addition to genotypic testing for HIV drug resistance: evaluation of resistance assays (ERA) trial investigators.
Dunn DT, Green H, Loveday C, Rinehart A, Pillay D, Fisher M, McCormack S, Babiker AG, Darbyshire JH; Evaluation of Resistance Assays (ERA) Trial Investigators. Dunn DT, et al. Among authors: mccormack s. J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):553-9. doi: 10.1097/01.qai.0000148533.12329.96. J Acquir Immune Defic Syndr. 2005. PMID: 15793365 Clinical Trial.
When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.
HIV-CAUSAL Collaboration; Cain LE, Logan R, Robins JM, Sterne JA, Sabin C, Bansi L, Justice A, Goulet J, van Sighem A, de Wolf F, Bucher HC, von Wyl V, Esteve A, Casabona J, del Amo J, Moreno S, Seng R, Meyer L, Perez-Hoyos S, Muga R, Lodi S, Lanoy E, Costagliola D, Hernan MA. HIV-CAUSAL Collaboration, et al. Ann Intern Med. 2011 Apr 19;154(8):509-15. doi: 10.7326/0003-4819-154-8-201104190-00001. Ann Intern Med. 2011. PMID: 21502648 Free PMC article.
Biomedical prevention: state of the science.
McCormack SM, Gafos M, Desai M, Cohen MS. McCormack SM, et al. Clin Infect Dis. 2014 Jul;59 Suppl 1(Suppl 1):S41-6. doi: 10.1093/cid/ciu297. Clin Infect Dis. 2014. PMID: 24926033 Free PMC article.
514 results